ArticleCancer medicine2023

Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.

Yujie Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.